Mark Pollack to Remission Induction
This is a "connection" page, showing publications Mark Pollack has written about Remission Induction.
Connection Strength
0.431
-
D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am J Psychiatry. 2013 Jul; 170(7):751-8.
Score: 0.110
-
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J Psychiatr Res. 2008 Oct; 42(14):1176-84.
Score: 0.076
-
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42.
Score: 0.072
-
Establishment of remission criteria for anxiety disorders. J Clin Psychiatry. 2003; 64 Suppl 15:40-5.
Score: 0.053
-
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 12:24-9.
Score: 0.046
-
Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. J Clin Psychiatry. 2001; 62 Suppl 19:20-5.
Score: 0.046
-
Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology. 2014 May; 39(6):1340-6.
Score: 0.028